Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CA9 | Q16790 | 3/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.59 |
| ▸ | ESR1 | P03372 | 3/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.57 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.50 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11323594 | 0.93 | PDCD1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4923900 | 0.90 | TSHR (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11323607 | 0.89 | KMT2A (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5152870 | 0.86 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10885498 | 0.86 | PDCD1 (0.49) | CA12CA1CA2CA7CA9 | |
| Isopropyl 4-Hydroxybenzoate SCHEMBL4729205 | 0.83 | CA12 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18297774 | 0.80 | TSHR (0.57) | LMNANPC1RAB9ATP53TSHR | |
| SCHEMBL11327383 | 0.80 | TSHR (0.48) | ALDH1A1LMNANPC1HTTTP53 | |
| SCHEMBL7172794 | 0.79 | CA12 (0.63) | CA12CA1CA2CA7CA9 | |
| Paraben SCHEMBL28070554 | 0.79 | KMT2A (0.45) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | claimed |
| US-20180077925-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2018-03-22 | — | — | US | claimed |
| EP-3265135-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | Wilson, John Paul (US) | 2018-01-10 | — | — | EP | claimed |
| WO-2016144907-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2016-09-15 | — | — | WO | claimed |
| EP-1613302-B1 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORP (US) | 2009-12-23 | — | — | EP | claimed |
| EP-1793871-A2 | NON-ABSORBENT AND ABSORBENT ARTICLES FOR INHIBITING THE PRODUCTION OF EXOPROTEINS | Kimberly-Clark Worldwide, Inc. (US) | 2007-06-13 | — | — | EP | claimed |
| US-7128923-B2 | Preserved and stable compositions containing peptide copper complexes and method related thereto | PROCYTE CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| WO-2006038980-A2 | NON-ABSORBENT AND ABSORBENT ARTICLES FOR INHIBITING THE PRODUCTION OF EXOPROTEINS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2006-04-13 | — | — | WO | claimed |
| US-20060067990-A1 | Absorbent articles for inhibiting the production of exoproteins | KIMBERLY-CLARK WORLDWIDE, INC. | 2006-03-30 | — | — | US | claimed |
| US-6897281-B2 | Breathable polyurethanes, blends, and articles | NOVEON IP HOLDINGS CORP. (US) | 2005-05-24 | — | — | US | claimed |
| WO-1994012115-A1 | PROTECTIVE MEDICAL GLOVE AND ANTIBACTERIAL/ANTIPERSPIRANT COMPOSITION FOR REDUCING BACTERIAL GROWTH DURING USE OF MEDICAL GLOVES | BUCHANAN, INC. (US) | 1994-06-09 | — | — | WO | claimed |
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-3592329-B1 | USE OF COMPATIBLE SOLUTES | SUSONITY Commercial GmbH (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-20260041615-A1 | FOAMING MIXED ALCOHOL/WATER COMPOSITIONS COMPRISING A STRUCTURED ALKOXYLATED SILOXANE | ECOLAB USA INC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4340807-B1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | LUBRIZOL ADVANCED MAT INC (US) | 2026-01-28 | — | — | EP | disclosed |
| WO-1994012115-A1 | PROTECTIVE MEDICAL GLOVE AND ANTIBACTERIAL/ANTIPERSPIRANT COMPOSITION FOR REDUCING BACTERIAL GROWTH DURING USE OF MEDICAL GLOVES | BUCHANAN, INC. (US) | 1994-06-09 | — | — | WO | disclosed |
| US-5053219-A | Colloids of calcium phosphocasinate, low lactose concentration; natural appearance, storage stability | RHONE-ELECTRA S.A. (CH) | 1991-10-01 | — | — | US | disclosed |
| WO-1991013617-A1 | ANTIMICROBIAL PRESERVATIVE SYSTEM COMPRISING A FORMALDEHYDE SUBSTITUTED HYDANTOIN | THE MCINTYRE GROUP, LTD. (US) | 1991-09-19 | — | — | WO | disclosed |
| US-5037843-A | Cold stability-anhydrous liquid; containing polyhydroxy alcohol solvent and alkalizing agent | THE MCINTYRE GROUP, LTD. (US) | 1991-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | TYR, SCO2, HBB | CA12 3080/4885CA1 4057/4885CA2 1535/4885 |
| US-20060067990-A1 | Absorbent articles for inhibiting the production of exoproteins | SLC43A1, MRPL21, SLC7A5 | CA12 3078/4885CA1 3676/4885CA2 1846/4885 |
| US-20260041615-A1 | FOAMING MIXED ALCOHOL/WATER COMPOSITIONS COMPRISING A STRUCTURED ALKOXYLATED SILOXANE | SMURF1, SMURF2, ALKBH3 | CA12 3622/4885CA1 3920/4885CA2 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.